Regenerative medicine company CollPlant announced that they have received authorization from the Chief Scientist of Israel's Ministry of Economy to partially fund their 2016 development project. CollPlant is exploring new uses for their human collagen-based medical products, including the development of a bioink material for use in the 3D printing of human tissue and organs. The ₪5.6 million ($1,453,564) grant awarded by the Chief Scientist is expected to cover 50% of CollPlant's projected ₪12 million ($3,114,780) development costs. You can read more over on